Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 70Breast Neoplasms 64Neoplasms 35Carcinoma, Non-Small-Cell Lung 29Neoplasm Metastasis 20Triple Negative Breast Neoplasms 18Lung Neoplasms 13Ovarian Neoplasms 12Adenocarcinoma 12Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Melanoma 10Head and Neck Neoplasms 8Fallopian Tube Neoplasms 7Cholangiocarcinoma 7Urinary Bladder Neoplasms 6Recurrence 6Esophageal Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Digestive System Neoplasms 5Colorectal Neoplasms 5Carcinoma, Ovarian Epithelial 5Uterine Cervical Neoplasms 4Sarcoma, Ewing 4Sarcoma 4Prostatic Neoplasms 4Pancreatic Diseases 4Inflammatory Breast Neoplasms 4Gallbladder Neoplasms 4Endocrine Gland Neoplasms 4

Interventions

Sunitinib 4Everolimus 4Fluorouracil 3Temozolomide 2Streptozocin 2Octreotide 2Leucovorin 2Irinotecan 2sargramostim 1sapanisertib 1pasireotide 1napabucasin 1motesanib diphosphate 1montanide ISA 51 1irinotecan sucrosofate 1incomplete Freund's adjuvant 1ibrutinib 1ganitumab 1cabozantinib 1batifiban 1aflibercept 1Wound Healing 1Thalidomide 1Taxes 1Sorafenib 1Salts 1Plastic Surgery Procedures 1Paclitaxel 1Oxaliplatin 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenoma, Islet Cell × Albumin-Bound Paclitaxel × Clear all
NCT02231723 2023-11-18

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

Sumitomo Pharma America, Inc.

Phase 1 Completed
139 enrolled
Gastrointestinal

Pancreatic cancer, adult, Digestive System Neoplasms, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Islet Cell, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡